Tekla Healthcare Investors Stock Price on November 6, 2024
| HQH Stock | USD 17.11 0.23 1.33% |
Below is the normalized historical share price chart for Tekla Healthcare Investors extending back to April 23, 1987. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Tekla Healthcare stands at 17.11, as last reported on the 13th of December 2024, with the highest price reaching 17.27 and the lowest price hitting 17.04 during the day.
If you're considering investing in Tekla Stock, it is important to understand the factors that can impact its price. Tekla Healthcare Inv owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.11, which indicates the firm had a -0.11% return per unit of risk over the last 3 months. Tekla Healthcare Investors exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Tekla Healthcare's Risk Adjusted Performance of (0.05), variance of 1.09, and Coefficient Of Variation of (1,394) to confirm the risk estimate we provide.
The Tekla Healthcare's current Other Stockholder Equity is estimated to increase to about 1.1 B, while Total Stockholder Equity is projected to decrease to under 667.3 M. . As of now, Tekla Healthcare's Price To Sales Ratio is decreasing as compared to previous years. The Tekla Healthcare's current Price Sales Ratio is estimated to increase to 112.64, while Price Earnings Ratio is projected to decrease to 8.11. Tekla Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of January 1988 | 200 Day MA 17.6767 | 50 Day MA 18.076 | Beta 0.736 |
Tekla |
Sharpe Ratio = -0.1098
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HQH |
Estimated Market Risk
| 1.05 actual daily | 9 91% of assets are more volatile |
Expected Return
| -0.11 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Tekla Healthcare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tekla Healthcare by adding Tekla Healthcare to a well-diversified portfolio.
Price Book 0.8285 | Book Value 19.905 | Enterprise Value 887.4 M | Price Sales 90.6718 | Shares Outstanding 50.6 M |
Related Headline
Diamond Hill Headline on 6th of November 2024
Diamond Hill Investment Group Third Quarter 2024 Earnings EP... by finance.yahoo.com
Diamond Hill Investment Group Third Quarter 2024 Results Key Financial Results Revenue US39.0m up...
Tekla Healthcare Valuation on November 6, 2024
It is possible to determine the worth of Tekla Healthcare on a given historical date. On November 6, 2024 Tekla was worth 17.94 at the beginning of the trading date compared to the closed value of 17.67. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Tekla Healthcare stock. Still, in general, we apply an absolute valuation method to find Tekla Healthcare's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Tekla Healthcare where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Tekla Healthcare's related companies.
| Open | High | Low | Close | Volume | |
| 17.55 | 17.68 | 17.50 | 17.64 | 101,900 | |
11/06/2024 | 17.94 | 18.04 | 17.52 | 17.67 | 154,200 |
| 17.67 | 17.93 | 17.67 | 17.79 | 140,500 |
| Backtest Tekla Healthcare | | | Tekla Healthcare History | | | Tekla Healthcare Valuation | Previous | Next |
Tekla Healthcare Trading Date Momentum on November 6, 2024
| On November 07 2024 Tekla Healthcare Investors was traded for 17.79 at the closing time. Highest Tekla Healthcare's price during the trading hours was 17.93 and the lowest price during the day was 17.67 . The net volume was 140.5 K. The overall trading history on the 7th of November contributed to the next trading period price growth. The trading delta at closing time to the next next day price was 0.68% . The trading price change to current price is 5.77% . |
Tekla Healthcare Inv Fundamentals Correlations and Trends
By evaluating Tekla Healthcare's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Tekla Healthcare's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Tekla financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Tekla Healthcare Stock history
Tekla Healthcare investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Tekla is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Tekla Healthcare Inv will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Tekla Healthcare stock prices may prove useful in developing a viable investing in Tekla Healthcare
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 56.9 M | 30.4 M | |
| Net Loss | -174.8 M | -166.1 M |
Tekla Healthcare Stock Technical Analysis
Tekla Healthcare technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Tekla Healthcare Period Price Range
Low | December 13, 2024
| High |
0.00 | 0.00 |
Tekla Healthcare Investors cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Tekla Healthcare December 13, 2024 Market Strength
Market strength indicators help investors to evaluate how Tekla Healthcare stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Tekla Healthcare shares will generate the highest return on investment. By undertsting and applying Tekla Healthcare stock market strength indicators, traders can identify Tekla Healthcare Investors entry and exit signals to maximize returns
Tekla Healthcare Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Tekla Healthcare's price direction in advance. Along with the technical and fundamental analysis of Tekla Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Tekla to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | (0.23) | |||
| Treynor Ratio | (0.14) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Tekla Stock analysis
When running Tekla Healthcare's price analysis, check to measure Tekla Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tekla Healthcare is operating at the current time. Most of Tekla Healthcare's value examination focuses on studying past and present price action to predict the probability of Tekla Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tekla Healthcare's price. Additionally, you may evaluate how the addition of Tekla Healthcare to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stocks Directory Find actively traded stocks across global markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |